Reply to the letter by David Buis regarding his comments on the Article "Comparative outcomes of cefazolin versus Anti-Staphylococcal Penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post-hoc analysis multicentre French cohort study" by Lecomte et al.